YP4

N-[(1R)-1-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine

Created: 2021-03-18
Last modified:  2021-06-30

Find related ligands:

Chemical Details

Formal Charge0
Atom Count48
Chiral Atom Count1
Bond Count50
Aromatic Bond Count17
2D diagram of YP4

Chemical Component Summary

NameN-[(1R)-1-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine
Systematic Name (OpenEye OEToolkits)~{N}-[(1~{R})-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine
FormulaC22 H22 F3 N
Molecular Weight357.412
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01FC(F)(F)c1cccc(CCCNC(C)c2cccc3ccccc32)c1
SMILESCACTVS3.385C[CH](NCCCc1cccc(c1)C(F)(F)F)c2cccc3ccccc23
SMILESOpenEye OEToolkits2.0.7CC(c1cccc2c1cccc2)NCCCc3cccc(c3)C(F)(F)F
Canonical SMILESCACTVS3.385 C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c2cccc3ccccc23
Canonical SMILESOpenEye OEToolkits2.0.7 C[C@H](c1cccc2c1cccc2)NCCCc3cccc(c3)C(F)(F)F
InChIInChI1.03 InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1
InChIKeyInChI1.03 VDHAWDNDOKGFTD-MRXNPFEDSA-N

Drug Info: DrugBank

DrugBank IDDB01012 
NameCinacalcet
Groups approved
DescriptionCinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. It is used to treat hyperparathyroidism due to parathyroid tumours or renal failure.
Synonyms
  • (R)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
  • Cinacalcet
  • N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
  • CNC
  • Cinacalcet hydrochloride
Brand Names
  • Reddy-cinacalcet
  • Cinacalcet Accordpharma
  • Apo-cinacalcet
  • Mylan-cinacalcet
  • PMS-cinacalcet
IndicationFor the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease who are on hemodialysis or peritoneal dialysis. Also for the treatment of hypercalcemia in patients with parathyroid carcinoma.
Categories
  • Anti-Parathyroid Agents
  • Calcimimetic Agents
  • Calcium Homeostasis
  • Calcium-Regulating Hormones and Agents
  • Calcium-sensing Receptor Agonist
ATC-CodeH05BX01
CAS number226256-56-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Extracellular calcium-sensing receptorMAFYSCCWVLLALTWHTSAYGPDQRAQKKGDIILGGLFPIHFGVAAKDQD...unknownagonist
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Cytochrome P450 2D6MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...unknowninhibitor
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1201284
PubChem 156419
ChEMBL CHEMBL1201284
ChEBI CHEBI:48390
CCDC/CSD TOKSES01